MedTrace Logo

NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)

NCT04969471 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2026-03-31

No results posted yet for this study

Summary

This study is designed to compare the safety and effectiveness of blood clot (thrombus) removal in subjects presenting with ST-segment elevation myocardial infarction (STEMI) with the enVast coronary system versus conventional intervention.

Conditions

  • Segment Elevation Myocardial Infarction (STEMI)

Interventions

DEVICE

enVast stent

In addition to conventional treatment, the treating physician will deploy as the first measure to obtain reperfusion, a enVast stent at the occlusion site in order to withdraw the clot.

PROCEDURE

conventional treatment

Treatment strategies may include balloon angioplasty, manual aspiration thrombectomy and/or coronary stenting.

Sponsors & Collaborators

  • Vesalio

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-09
Primary Completion
2026-06-01
Completion
2027-08-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969471 on ClinicalTrials.gov